A phase I/IIa single and multiple ascending dose study for management of intractable pain in oncology patients

Trial Profile

A phase I/IIa single and multiple ascending dose study for management of intractable pain in oncology patients

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 24 Oct 2017

At a glance

  • Drugs Cannabidiol (Primary) ; Tetrahydrocannabinol (Primary)
  • Indications Pain
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 24 Oct 2017 Status changed from planning to not yet recruiting. as reported in an Aphria media release
    • 24 Oct 2017 According to an Aphria media release, this trial will commence at Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney and will be supervised by Professor Stephen Clarke OAM.
    • 14 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top